B&R Technology Merger
BRTMW · NASDAQ
BRTMW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 15.27K
- Volume
- 500
- Open price
- $0.2402
- High today
- $0.2402
- Low today
- $0.2402
- 52 Week high
- $0.45
- 52 Week low
- $0.2218
B&R Technology Merger (BRTMW) at a glance
As of Nov 5, 2026, B&R Technology Merger (BRTMW) shares are priced at $0.2402, giving the company a price-to-earnings ratio of 0.00.
Volume so far is 500 shares, below the average of 15.27K shares a day.
Over the past year B&R Technology Merger has ranged from $0.2218 to $0.45, and now sits 8% of the way up that range.
BRTMW news
- Press releasePRNewswire
- Press releasePRNewswire
B&R Technology Merger Corp. Announces Closing of Exercise of IPO Over-Allotment Option
- Press releasePRNewswire
B&R Technology Merger Corp. Completes $325 Million Initial Public Offering
- Press releasePRNewswire
B&R Technology Merger Corp. Announces Pricing of $325 Million Initial Public Offering
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003+0.00%
- RCTRedCloud Holdings$0.0424+41.33%
- SHFSSHF Holdings$0.0263−1.13%
- SDASunCar Technology Group$0.3765+144.80%
- WDLFDecentral Life$0.0004+100.00%
- SEIISharing Economy International$0.0001−50.00%
- SOXLDirexion Shares ETF Trust$45.97+12.48%
- VIVKVivakor$0.4962+34.11%
- MASNMaison Luxe$0.0003−33.33%
- NBNDNetBrands$0.0005+11.11%
- NVDANVIDIA$186.64+2.78%
- INTCIntel$56.28+7.71%
Newly listed
Companies that went public in the past six weeks
- NARANarragansett Bancorp$10.84−0.28%
- ASPEAspen Neuroscience$12.44+5.78%
- BBTXBambusa Therapeutics$15.73−0.76%
- GBCGEORGIA BANKING$33.10−1.93%
- BHAIUBHAV Acquisition Corp II$9.99+0.00%
- SCQCUSPACCircle Acquisition$10.00+0.10%
- LYCALycia Therapeutics$30.50+5.90%
- DAVIDAVION HEALTHCARE$1.59+21.37%
- TCXBTCGX Acquisition Corp. II$10.20−0.49%
- CTYCITY THERAPEUTICS$18.25+6.91%
- IAMIambic Therapeutics$10.17−12.63%
- AMROAmaero$5.45+1.87%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.